Civica is new non-profit in US

A group of seven US healthcare organisations representing around 500 hospitals has realised plans to form a non-profit generics company, as a means to tackle shortages and address rising drug costs, officially establishing itself as Civica Rx and naming former Amgen executive Martin VanTrieste as its chief executive officer.

A group of seven US healthcare organisations representing around 500 hospitals has realised plans to form a non-profit generics company, as a means to tackle shortages and address rising drug costs, officially establishing itself as Civica Rx and naming former Amgen executive Martin VanTrieste as its chief executive officer.

The number of representatives has risen since it was announced in January this year (Generics bulletin, 26 January 2018, page...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Archive

More from Generics Bulletin